International Pathogen Surveillance Network launches catalytic grant fund for pathogen genomics
Geneva- February 2024- The World Health Organization (WHO) announced US$ 4 million in funding from donors to create a catalytic grant fund for organizations working... Read more.
Novartis Appoints Sloan Simpson as Global Head of Investor Relations
February 2024- Novartis announced that Sloan Simpson has been appointed Global Head of Investor Relations, reporting to CFO Harry Kirsch, effective April 1, 2024.... Read more.
Cancer survivor student donates Hair to childhood Cancer sufferers
UAE- February 2024- Aurelia Reeves, a Grade 5 pupil at the leading IB boarding school in the region, Al Jadaf-based Swiss International School Dubai, recently marked... Read more.
3M Announces Filing of Form 10 Registration Statement
February 2024- 3M announced the filing of a Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) for the planned spin-off of its... Read more.
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
Washington- February 2024- Danaher Corporation announced that it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with... Read more.
New guidelines for managing sickle cell disease during pregnancy
February 2024- Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced the publication of a peer-reviewed study containing new consensus... Read more.
Ethiopia on $5 billion African medical tourism map with one of most significant healthcare developments
Ethiopia-February 2024- In a milestone for one of Africaโs biggest healthcare developments, Roha Medical Campus (RMC) announces it has received fresh investment... Read more.
GSK completes acquisition of Aiolos Bio
February 2024- GSK today announced that it has completed the acquisition of Aiolos Bio (Aiolos), a clinical-stage biopharmaceutical company focused on addressing... Read more.
New collaboration between Boehringer Ingelheim and Sleip leverages AI technology
February 2024- A new global commercial partnership between Boehringer Ingelheim and Sleip will expand access to AI to enhance the detection, diagnosis and treatment... Read more.
CVS Healthยฎ to participate at the 45th Annual Raymond James Institutional Investors Conference
February 2024โ CVS Healthยฎ announced that Executive Vice President and Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at... Read more.
